Aspirin And Extended - Release Dipyridamole Capsules, 25 Mg / 200 Mg Capsule
Product Images NDC 49884-007

5 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Aspirin And Extended - Release Dipyridamole Capsules, 25 Mg / 200 Mg (NDC 49884-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aspirin-struct.jpg (Aspirin And Extended Release Dypyridamole Capsules 1)

Aspirin-struct.jpg (Aspirin And Extended Release Dypyridamole Capsules 1)
Chemical structure diagram of the active ingredient Dipyridamole with molecular formula C24H40N8O4 and molecular weight 504.63.*
FDA Label Image

Aspirin-struct-2.jpg (Aspirin And Extended Release Dypyridamole Capsules 2)

Aspirin-struct-2.jpg (Aspirin And Extended Release Dypyridamole Capsules 2)
Chemical structure diagram of Aspirin (acetylsalicylic acid) showing its molecular formula C9H8O4 and molecular weight 180.16. The structure includes a benzene ring with a carboxyl group and an ester group attached.*
FDA Label Image

Aspirin-graph.jpg (Aspirin And Extended Release Dypyridamole Capsules 3)

Aspirin-graph.jpg (Aspirin And Extended Release Dypyridamole Capsules 3)
A line chart depicting cumulative stroke rate (%) over 24 months of follow-up for different treatment groups: Aspirin and extended-release dipyridamole, aspirin (ASA) 25 mg, extended-release dipyridamole (ER-DP) 200 mg, and placebo. The x-axis shows months of follow-up, and the y-axis shows cumulative stroke rate percentage. Data is illustrated with distinct lines and markers for each group.*
FDA Label Image

Aspirin (Aspirin And Extended Release Dypyridamole Capsules 4)

Aspirin (Aspirin And Extended Release Dypyridamole Capsules 4)
Label for Aspirin and Extended-Release Dipyridamole Capsules, 25 mg / 200 mg, oral dosage form. The label states the product contains 60 capsules and is for prescription use only. It includes storage instructions, manufacturer information (Par Formulations Private Limited, India), and distributor (Par Pharmaceutical, U.S.A.). The label features the PAR Pharmaceutical logo and the product NDC 49884-007-02.*
FDA Label Image

Aspirin (Aspirin And Extended Release Dypyridamole Capsules 5)

Aspirin (Aspirin And Extended Release Dypyridamole Capsules 5)
Packaging label for Aspirin and Extended-Release Dipyridamole Capsules 25 mg / 200 mg by Par Health USA, LLC. The label indicates a unit-of-use container with 60 capsules, bears NDC 49884-007-02, and includes dosage information, storage instructions, and manufacturer details including Par Formulations Private Limited in India. The design features the product name, strength, and regulatory information, along with the PAR Pharmaceutical logo and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.